Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 426

The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.

Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers

Open access
Bhonsale, Aditya, Groeneweg, Judith A., James, Cynthia A., Dooijes, Dennis, Tichnell, Crystal, Jongbloed, Jan D. H., Murray, Brittney, te Riele, Anneline S. J. M., van den Berg, Maarten P., Bikker, Hennie, Atsma, Douwe E., de Groot, Natasja M., Houweling, Arjan C., van der Heijden, Jeroen F., Russell, Stuart D., Doevendans, Pieter A., van Veen, Toon A., Tandri, Harikrishna, Wilde, Arthur A., Judge, Daniel P., van Tintelen, J. Peter, Calkins, Hugh, Hauer, Richard N.·2015·European Heart Journal

Abstract

AIMS: We sought to determine the influence of genotype on clinical course and arrhythmic outcome among arrhythmogenic right ventricular dysplasia/cardiomyopathy (ARVD/C)-associated mutation carriers. METHODS AND RESULTS: Pathogenic mutations in desmosomal and non-desmosomal genes were identified in 577 patients (241 families) from USA and Dutch ARVD/C cohorts. Patients with sudden cardiac death (SCD)/ventricular fibrillation (VF) at presentation (n = 36) were younger (median 23 vs. 36 years; P < 0.001) than those presenting with sustained monomorphic ventricular tachycardia (VT). Among 541 subjects presenting alive, over a mean follow-up of 6 ± 7 years, 12 (2%) patients died, 162 (30%) had sustained VT/VF, 78 (14%) manifested left ventricular dysfunction (EF < 55%), 28 (5%) experienced heart failure (HF), and 10 (2%) required cardiac transplantation. Patients (n = 22; 4%) with >1 mutation had significantly earlier occurrence of sustained VT/VF (mean age 28 ± 12 years), lower VT-/VF-free survival (P = 0.037), more frequent left ventricular dysfunction (29%), HF (19%) and cardiac transplantation (9%) when compared with those with only one mutation. Desmoplakin mutation carriers experienced more than four-fold occurrence of left ventricular dysfunction (40%) and HF (13%) than PKP2 carriers. Missense mutation carriers had similar death-/transplant-free survival and VT/VF penetrance (P = 0.137) when compared with those with truncating or splice site mutations. Men are more likely to be probands (P < 0.001), symptomatic (P < 0.001) and have earlier and more severe arrhythmic expression. CONCLUSIONS: Presentation with SCD/VF occurs at a significantly younger age when compared with sustained monomorphic VT. The genotype of ARVD/C mutation carriers impacts clinical course and disease expression. Male sex negatively modifies phenotypic expression.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehu509

Cites

27 of 27 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 27 references

Cited by

See all 426

Metadata

Authors
Bhonsale, A., Groeneweg, J. A., James, C. A., Dooijes, D., Tichnell, C., Jongbloed, J. D. H., Murray, B., te Riele, A. S. J. M., van den Berg, M. P., Bikker, H., Atsma, D. E., de Groot, N. M., Houweling, A. C., van der Heijden, J. F., Russell, S. D., Doevendans, P. A., van Veen, T. A., Tandri, H., Wilde, A. A., Judge, D. P., van Tintelen, J. P., Calkins, H., & Hauer, R. N.
Venue
European Heart Journal
Published
2015-01-23
Volume
36
Issue
14
Pages
847-855
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2158221215
Cited by
426
References
27
FWCI
29.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. https://app.cochat.ai/papers/10.1093/eurheartj/ehu509
The paper
Bhonsale, A., Groeneweg, J. A., James, C. A., Dooijes, D., Tichnell, C., Jongbloed, J. D. H., Murray, B., te Riele, A. S. J. M., van den Berg, M. P., Bikker, H., Atsma, D. E., de Groot, N. M., Houweling, A. C., van der Heijden, J. F., Russell, S. D., Doevendans, P. A., van Veen, T. A., Tandri, H., Wilde, A. A., . . . Hauer, R. N. (2015). Impact of genotype on clinical course in arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated mutation carriers. European Heart Journal. https://doi.org/10.1093/eurheartj/ehu509

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.